Display Settings:

Format

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
N Engl J Med. 2011 Oct 6;365(14):1336-8. doi: 10.1056/NEJMe1101326.

Steady progress against HER2-positive breast cancer.

Comment on

  • Adjuvant trastuzumab in HER2-positive breast cancer. [N Engl J Med. 2011]
PMID:
21991956
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Atypon
    Loading ...
    Write to the Help Desk